ISSN: 1000-467X

Journal Home

Chinese Journal of Cancer Unclaimed

BMC United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Chinese Journal of Cancer is a journal indexed in SJR in Oncology with an H index of . It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1507 €. The scope of the journal is focused on cancer. It is published in English.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Oncology (-)

Price

1507 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

-

SJR Impact factor

-

H Index

-

Total Docs (Last Year)

-

Total Docs (3 years)

-

Total Refs

-

Total Cites (3 years)

-

Citable Docs (3 years)

-

Cites/Doc (2 years)

-

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Cancer

Best articles by citations

Epstein-Barr virus and Burkitt lymphoma

The cellular decision between apoptosis and autophagy

Epstein-Barr virus and the origin of Hodgkin lymphoma

Gastrointestinal stromal tumor and its targeted therapeutics

Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model

MicroRNAs in nasopharyngeal carcinoma

Clinical implications of hedgehog signaling pathway inhibitors

Novel strategies in glioblastoma surgery aim at safe, supra-maximum resection in conjunction with local therapies

Synovial sarcoma: a rare presentation of parapharyngeal mass

Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting

Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer

Impact of fine particles in ambient air on lung cancer

SHOW MORE ARTICLES

Primary cutaneous marginal zone B-cell lymphoma with amyloid deposition: report of two cases with review of literature

GWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseases

Damage of nasal mucociliary movement after intensity-modulated radiation therapy of nasopharyngeal carcinoma

Current development of the second generation of mTOR inhibitors as anticancer agents

Association of a single nucleotide polymorphism at 6q25.1,rs2046210, with endometrial cancer risk among Chinese women

Platelet-derived growth factor signaling in human malignancies

A modified method for locating parapharyngeal space neoplasms on magnetic resonance images: implications for differential diagnosis

Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma

Implication of platelet-derived growth factor receptor alpha in prostate cancer skeletal metastasis

Computed tomography features of enlarged tonsils as a first symptom of non-Hodgkin's lymphoma

Association between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis

Investigation of osteosarcoma genomics and its impact on targeted therapy: an international collaboration to conquer human osteosarcoma